African Journal of
Biochemistry Research

  • Abbreviation: Afr. J. Biochem. Res.
  • Language: English
  • ISSN: 1996-0778
  • DOI: 10.5897/AJBR
  • Start Year: 2007
  • Published Articles: 413

Full Length Research Paper

Profile of CA 15-3 and CEA during breast cancer chemotherapy at Ouagadougou, Burkina Faso

Fabienne Marie SOUDRE
  • Fabienne Marie SOUDRE
  • Unit of Training and Research in Health Sciences, University Joseph Ki-Zerbo, 03 P. O. Box 7021, Ouagadougou, Burkina Faso.
  • Google Scholar
Alice KIBA
  • Alice KIBA
  • Unit of Training and Research in Health Sciences, University Joseph Ki-Zerbo, 03 P. O. Box 7021, Ouagadougou, Burkina Faso.
  • Google Scholar
Arnaud KOURAOGO
  • Arnaud KOURAOGO
  • Unit of Training and Research in Health Sciences, University Joseph Ki-Zerbo, 03 P. O. Box 7021, Ouagadougou, Burkina Faso.
  • Google Scholar
Raoul KARFO
  • Raoul KARFO
  • Unit of Training and Research in Health Sciences, University Joseph Ki-Zerbo, 03 P. O. Box 7021, Ouagadougou, Burkina Faso.
  • Google Scholar
Aboubacar BAMBARA
  • Aboubacar BAMBARA
  • Unit of Training and Research in Health Sciences, University Joseph Ki-Zerbo, 03 P. O. Box 7021, Ouagadougou, Burkina Faso.
  • Google Scholar
Arsène KAGAMBEGA
  • Arsène KAGAMBEGA
  • University Hospital Centre of Bogodogo, 14 P. O. Box 371, Ouagadougou, Burkina Faso.
  • Google Scholar
Elie KABRE
  • Elie KABRE
  • Unit of Training and Research in Health Sciences, University Joseph Ki-Zerbo, 03 P. O. Box 7021, Ouagadougou, Burkina Faso.
  • Google Scholar
Jean SAKANDE
  • Jean SAKANDE
  • Unit of Training and Research in Health Sciences, University Joseph Ki-Zerbo, 03 P. O. Box 7021, Ouagadougou, Burkina Faso.
  • Google Scholar


  •  Received: 30 August 2021
  •  Accepted: 07 October 2021
  •  Published: 31 October 2021

References

Abed SN, Mahdi HS, Sahib AS, Mousa HM, Almaali A, Al Haydar M, Mohsin KK (2020). Serum Levels of Cancer Antigen 15.3 and Estrogen in a Samples of Iraqi Women with Breast Cancer Treated with Anastrazole. International Journal of Pharmaceutical Research 1:1604-1608.

 

Ashour Byomy LG, Zahraan F, Aref M, Ibrahim Mosa MF (2021). Assessment of CEA and CA15-3 as Potential Prognostic Markers for Breast Cancer in Egyptian Females. Alfarama Journal of Basic and Applied Sciences 2(1):44-50.
Crossref

 
 

Bushi S, Trebicka A (2021). The Role of Tumor Markers for Evaluation the Course of Chemotherapy. ARC Journal of Cancer Science 7(1):01-05.
Crossref

 
 

Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E (2019). Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of Oncology 30(8):1194-1220.
Crossref

 
 

Deliu I, Cristina M, Dumitru G (2018). Utility of tumor markers as a diagnostic tool. Current Trends in Natural Sciences 7(14) :272-275.

 
 

Dubreuil J, Cachin F, Berriolo-Ridinger A, Skanjeti A (2017). Critères d'interprétation en imagerie cancérologique solide: RECIST, PERCIST…. Médecine Nucléaire 41(3):241-248.
Crossref

 
 

Duffy MJ (2006). Serum Tumor Markers in Breast Cancer: Are They of Clinical Value? Clinical Chemistry 52(3):345-351.
Crossref

 
 

Duffy MJ, Harbeck N, Nap M, Molina R, Nicolini A, Senkus E, Cardoso F (2017). Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM). European Journal of Cancer 75:284-298.
Crossref

 
 

Durand G, Beaudeux JL (2011). Biochimie médicale: Marqueurs actuels et perspectives. Lavoisier.

 
 

Ebeling FG, Stieber P. Untch M, Nagel D, Konecny GE, Schmitt UM, Fateh-Moghadam A, Seidel D (2002). Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. British Journal of Cancer, 86(8):1217-1222.
Crossref

 
 

Farahani H, Amri J, Alaee M, Mohaghegh F, Rafiee M (2020). Serum and Saliva Levels of Cancer Antigen 15-3, Carcinoembryonic Antigen, Estradiol, Vaspin, and Obestatin as Biomarkers for the Diagnosis of Breast Cancer in Postmenopausal Women. Laboratory Medicine 51(6):620-627.
Crossref

 
 

Gonssaud B, Goussot V, Berriolo-Riedinger A, Saïtta-Aribau E, Coutant C, Cochet A, Fumoleau P, Riedinger,JM (2017). Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer. Annales De Biologie Clinique 75(4):421-429.
Crossref

 
 

Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast Jr. RC (2007). American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Journal of Clinical Oncology 25(33):5287-5312.
Crossref

 
 

Imran AH, Al-atrachji SA, Al-mosawi KK (2021). Clinical important of E-Cadherin, CA15-3 and CEA in Diagnostic and Flow Up for Breast Cancer Patients. Indian Journal of Forensic Medicine and Toxicology 15(2).

 
 

Khodabakhsh F, Merikhian P, Eisavand MR, Farahmand L (2021). Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: A review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling. Cancer Cell International 21(1):1-11.
Crossref

 
 

Khushk M, Khan A, Rehman A, Sheraz S, Tunio YM, Rehman K, Rehman D, Ahmed M, Abbas K, Khan ME (2021). The Role of Tumor Markers: Carcinoembryonic Antigen and Cancer Antigen 15-3 in Patients With Breast Cancer. Cureus 13(7).
Crossref

 
 

Li J, Liu L, Feng Z, Wang X, Huang Y, Dai H, Zhang L, Song F, Wang D, Zhang P, Ma B, Li H, Zheng H, Song F, Chen K (2020). Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: A cohort study. Breast Cancer (Tokyo, Japan), 27(4).
Crossref

 
 

Li X, Dai D, Chen B, Tang H, Xie X, Wei W (2018). Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients. Disease Markers.
Crossref

 
 

Molina R, Auge JM, Farrus B, Zanón G, Pahisa J, Muñoz M, Torne A, Filella X, Escudero JM, Fernandez P, Velasco M (2010). Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer. Clinical Chemistry 56(7):1148-1157.
Crossref

 
 

Moschetti I, Cinquini M, Lambertini M, Levaggi A, Liberati A (2016). Follow-up strategies for women treated for early breast cancer. Cochrane Database of Systematic Reviews 5.
Crossref

 
 

Nan J, Li J, Li X, Guo G, Wen X, Tian Y (2017). Preoperative Serum Carcinoembryonic Antigen as a Marker for Predicting the Outcome of Three Cancers. Biomarkers in Cancer 9, 1179299X17690142.
Crossref

 
 

Oral O, Unverdi H, Kumcu E, Turkbey D, Dogan S, Hucumenoglu S (2020). Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas. Indian Journal of Pathology and Microbiology 63(4):551-558.
Crossref

 
 

Rasmy A, Abozeed W, Elsamany S, Baiomy ME, Nashwa A, Amrallah A, Hasaan E, Alzahrani A, Faris M, Alsaleh K, AlFaraj A (2016). Correlation of Preoperative Ki67 and Serum CA15.3 Levels with Outcome in Early Breast Cancers a Multi Institutional Study. Asian Pacific Journal of Cancer Prevention 17(7):3595-3600.
Crossref

 
 

Ruswendro D, Syamsu SA, Thabry R, Seweng A, Usman AN (2021). Association between molecular subtype of local advanced breast cancer with Ca 15-3 level. Breast Disease 40(s1):S119-S122.
Crossref

 
 

Shao Y, Sun X, He Y, Liu C, Liu H (2015). Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer. PLOS ONE 10(7):e0133830.
Crossref

 
 

Shi SR, Guo J, Cote RJ, Young L, Hawes D, Shi Y, Thu S, Taylor CR (1999). Applied Immunohistochemistry and Molecular Morphology 7(3):201.
Crossref

 
 

Uygur MM, Gümü? M (2021). The utility of serum tumor markers CEA and CA 15-3 for breast cancer prognosis and their association with clinicopathological parameters. Cancer Treatment and Research Communications 28:100402.
Crossref

 
 

Wu S, He Z, Zhou J, Sun J, Li F, Lin Q, Guo L, Lin H (2014). Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer. Breast (Edinburgh, Scotland) 23(1):88-93.
Crossref

 
 

Yoo YC, Park S, Kim HJ, Jung HE, Kim JY, Kim MH (2021). Preoperative Routine Laboratory Markers for Predicting Postoperative Recurrence and Death in Patients with Breast Cancer. Journal of Clinical Medicine 10(12):2610.
Crossref